Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · IEX Real-Time Price · USD
0.237
-0.026 (-9.78%)
At close: Apr 25, 2024, 4:00 PM
0.252
+0.015 (6.46%)
After-hours: Apr 25, 2024, 7:16 PM EDT
Portage Biotech Stock Forecast
PRTG's stock price has decreased by -92.43% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Portage Biotech stock has a target of 11, which predicts an increase of 4,541.35% from the current stock price of 0.24.
Analyst Consensus: Buy
* Price targets were last updated on Sep 7, 2023.
Analyst Ratings
The average analyst rating for PRTG stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +2,431.65% | Nov 29, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +4,541.35% | Sep 7, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +4,541.35% | Aug 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $9 | Strong Buy | Maintains | $21 → $9 | +3,697.47% | Aug 2, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.66
from -6.49
EPS Next Year
-0.53
from -0.66
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -0.68 | -0.55 | -0.55 |
| Avg | -0.66 | -0.53 | -0.53 |
| Low | -0.64 | -0.51 | -0.51 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.